
Understand what peptides are, how signaling peptides work, and why evidence differs from one compound to another.
Explore metabolic, mitochondrial, recovery, hormone, neurological, and tissue-biology research.
Learn the difference between FDA-approved therapies, compounded medications, and investigational research compounds.
Support the fundamentals first: movement, mindset, nutrition, light, sleep, and individualized medical care.
Peptide and metabolic research, explained clearly
Peptides are short chains of amino acids that can act as signaling molecules throughout the body. Some peptide-based medicines have established clinical uses, while other compounds discussed in peptide medicine remain investigational.
That distinction matters. At Team Wellness, we focus on what has actually been studied, the strength of the human evidence, known and unknown risks, and how emerging research fits into the bigger health picture.
Our approach starts with the Four Foundations of Health: Movement, Mindset, Nutrition and Light. Emerging therapies should complement those fundamentals, not replace them.
How does the process work?
Start with your health goals and questions. A qualified healthcare professional can review your history, discuss appropriate options, and explain where the evidence is strong, limited, or still emerging.
Team Wellness participates in clinical research under institutional review board oversight. Participation in research is different from receiving an FDA-approved treatment, and investigational compounds should be discussed with clear informed consent and medical oversight.
Explore areas of peptide research
Semax and Selank are synthetic peptides studied primarily in neurological and neurobehavioral research. Areas of interest include cognition, stress response, anxiety-related pathways, and neuroprotection.
MOTS-c is a mitochondrial-derived peptide being studied for its role in metabolic signaling, cellular energy, glucose metabolism, and responses to metabolic stress. Human research is still limited, and therapeutic benefits and long-term safety have not been established.
Retatrutide is an investigational triple-receptor agonist being studied in clinical trials for obesity and metabolic disease. Research has examined effects on body weight and metabolic measures.
CJC-1295 and ipamorelin are peptides studied for their effects on growth-hormone signaling.
Kisspeptin is a naturally occurring signaling peptide with an established role in reproductive physiology. It stimulates GnRH signaling and can influence LH and FSH. Researchers have studied kisspeptin in reproductive endocrinology, fertility, and hormone signaling. Individual effects depend on clinical context.
GHK-Cu is a naturally occurring copper-binding peptide studied in areas including skin biology, collagen signaling, wound biology, and hair-follicle research. Evidence varies substantially by application and route of administration.
BPC-157 and TB-500 are investigational compounds commonly discussed in recovery and tissue-repair research. Much of the interest comes from preclinical studies involving inflammation,angiogenesis, and tissue-healing pathways. Human evidence is limited.
BPC-157 is an investigational peptide studied primarily in laboratory and animal models involving gastrointestinal and tissue-healing pathways.